{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:42:50Z","timestamp":1788496970551,"version":"build-2803163510"},"reference-count":94,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,8,15]]},"abstract":"<jats:p>Background: Pathological biomarkers of Alzheimer\u2019s disease (AD) and other dementias can change decades before clinical symptoms. Lifestyle and health factors might be relevant modifiable risk factors for dementia. Many previous studies have been focusing on associations of lifestyle and health-related factors with clinical outcomes later in life. Objective: We aimed to determine to what extent midlife factors of lifestyle, inflammation, vascular, and metabolic health were associated with long-term changes in blood-based biomarkers of AD (amyloid beta (A\u03b2)) and neurodegeneration (neurofilament light chain (NfL); total tau(TTau)). Methods: In 1,529 Beaver Dam Offspring Study (BOSS) participants (mean age 49 years, standard deviation (SD)\u200a=\u200a9; 54% were women), we applied mixed-effects models with baseline risk factors as determinants and 10-year serum biomarker change as outcomes. Results: We found that education and inflammatory markers were associated with levels and\/or change over time across all three markers of AD and neurodegeneration in the blood. There were baseline associations of measures of cardiovascular health with lower A\u03b242\/A\u03b240. TTau changed little over time and was higher in individuals with diabetes. Individuals with lower risk in a number of cardiovascular and metabolic risk factors, including diabetes, hypertension, and atherosclerosis had slower accumulation of neurodegeneration over time, as determined by NfL levels. Conclusion: Various lifestyle and health factors, including education and inflammation, were associated with longitudinal changes of neurodegenerative and AD biomarker levels in midlife. If confirmed, these findings could have important implications for developing early lifestyle and health interventions that could potentially slow processes of neurodegeneration and AD.<\/jats:p>","DOI":"10.3233\/jad-221287","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T11:20:18Z","timestamp":1688124018000},"page":"1381-1395","source":"Crossref","is-referenced-by-count":13,"title":["Associations of Midlife Lifestyle and Health Factors with Long-Term Changes in Blood-Based Biomarkers of Alzheimer\u2019s Disease and Neurodegeneration"],"prefix":"10.1177","volume":"94","author":[{"given":"Natascha","family":"Merten","sequence":"first","affiliation":[{"name":"Division of Geriatrics and Gerontology, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"},{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"},{"name":"Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Alex","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Paulsen","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne D.","family":"Engelman","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Hancock","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"},{"name":"William S Middleton Memorial Veterans Hospital, Madision, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Geriatrics and Gerontology, Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"},{"name":"Wisconsin Alzheimer\u2019s Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla R.","family":"Schubert","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-221287_ref1","doi-asserted-by":"crossref","first-page":"j2856","DOI":"10.1136\/bmj.j2856","article-title":"Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: Modelling study","volume":"358","author":"Ahmadi-Abhari","year":"2017","journal-title":"BMJ"},{"key":"10.3233\/JAD-221287_ref3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221287_ref4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.pmbts.2019.07.006","article-title":"Fluid biomarker-based molecular phenotyping of Alzheimer\u2019s disease patients in research and clinical settings.","volume":"168","author":"Blennow","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.3233\/JAD-221287_ref5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: Towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221287_ref6","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-221287_ref7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-221287_ref8","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jalz.2016.06.001","article-title":"Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort","volume":"12","author":"Dage","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/alz.12404","article-title":"Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study","volume":"18","author":"O\u2019Bryant","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/WCO.0000000000000904","article-title":"Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer\u2019s disease","volume":"34","author":"Leuzy","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JAD-221287_ref11","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/gerona\/glz011","article-title":"Sensorineural impairments, cardiovascular risk factors, and 10-year incidence of cognitive impairment and decline in midlife: The Beaver Dam Offspring Study","volume":"74","author":"Schubert","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-221287_ref12","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/jgs.15886","article-title":"Brain aging in midlife: The Beaver Dam Offspring Study","volume":"67","author":"Schubert","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-221287_ref13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","article-title":"Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance","volume":"16","author":"Stern","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jamainternmed.2016.6807","article-title":"A comparison of the prevalence of dementia in the United States in 2000 and 2012","volume":"177","author":"Langa","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.3233\/JAD-221287_ref15","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-221287_ref16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer\u2019s disease: An analysis of population-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221287_ref17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","article-title":"Meta-analysis of Alzheimer\u2019s disease risk with obesity, diabetes, and related disorders","volume":"67","author":"Profenno","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-221287_ref18","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1111\/j.1467-789X.2010.00825.x","article-title":"Body mass index in midlife and late-life as a risk factor for dementia: A meta-analysis of prospective studies","volume":"12","author":"Anstey","year":"2011","journal-title":"Obes Rev"},{"key":"10.3233\/JAD-221287_ref19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2796.2010.02281.x","article-title":"Physical activity and risk of cognitive decline: A meta-analysis of prospective studies","volume":"269","author":"Sofi","year":"2011","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-221287_ref20","doi-asserted-by":"crossref","first-page":"e12212","DOI":"10.1002\/dad2.12212","article-title":"Cardiorespiratory fitness mitigates brain atrophy and cognitive decline in adults at risk for Alzheimer\u2019s disease","volume":"13","author":"Dougherty","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-221287_ref21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-221287_ref22","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000003837","article-title":"Intracranial atherosclerosis and dementia","volume":"88","author":"Dearborn","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-221287_ref23","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.atherosclerosis.2012.07.024","article-title":"Carotid atherosclerosis and 10-year changes in cognitive function","volume":"224","author":"Zhong","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.3233\/JAD-221287_ref24","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/jgs.12994","article-title":"Long-term systemic inflammation and cognitive impairment in a population-based cohort","volume":"62","author":"Wichmann","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-221287_ref25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/archoto.2011.15","article-title":"The prevalence of hearing impairment and associated risk factors","volume":"137","author":"Nash","year":"2011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.3233\/JAD-221287_ref26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neurobiolaging.2022.08.008","article-title":"Associations of sensory and motor function with blood-based biomarkers of neurodegeneration and Alzheimer\u2019s disease in midlife","volume":"120","author":"Paulsen","year":"2022","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-221287_ref27","doi-asserted-by":"crossref","first-page":"e12168","DOI":"10.1002\/dad2.12168","article-title":"Effects of pre-analytical procedures on blood biomarkers for Alzheimer\u2019s pathophysiology, glial activation, and neurodegeneration","volume":"13","author":"Ashton","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-221287_ref28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer\u2019s disease-related blood-based biomarkers: Results from the Standardization of Alzheimer\u2019s Blood Biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref31","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3233\/JAD-215096","article-title":"Effect of long-term storage on the reliability of blood biomarkers for Alzheimer\u2019s disease and neurodegeneration","volume":"85","author":"Schubert","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221287_ref32","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/lary.28244","article-title":"Cadmium, obesity, and education, and the 10-year incidence of hearing impairment: The Beaver Dam Offspring Study","volume":"130","author":"Dalton","year":"2020","journal-title":"Laryngoscope"},{"key":"10.3233\/JAD-221287_ref33","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Hadley","year":"2016"},{"key":"10.3233\/JAD-221287_ref34","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"10.3233\/JAD-221287_ref35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-140771","article-title":"Amyloid-\u03b2 42\/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer\u2019s disease: Validation of two novel assays","volume":"43","author":"Lewczuk","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221287_ref36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40520-021-02054-z","article-title":"Neurofilament light chain concentration in an aging population","volume":"34","author":"Ladang","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"10.3233\/JAD-221287_ref37","doi-asserted-by":"crossref","first-page":"25729","DOI":"10.18632\/aging.203790","article-title":"Factors influencing serum neurofilament light chain levels in normal aging","volume":"13","author":"Koini","year":"2021","journal-title":"Aging"},{"key":"10.3233\/JAD-221287_ref38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/acn3.50972","article-title":"Confounding effect of blood volume and body mass index on blood neurofilament light chain levels","volume":"7","author":"Manouchehrinia","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-221287_ref39","doi-asserted-by":"crossref","first-page":"15863","DOI":"10.1038\/s41598-022-20398-y","article-title":"Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters","volume":"12","author":"Hermesdorf","year":"2022","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-221287_ref40","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-221287_ref42","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.2017.3090","article-title":"Association between midlife vascular risk factors and estimated brain amyloid deposition","volume":"317","author":"Gottesman","year":"2017","journal-title":"JAMA"},{"key":"10.3233\/JAD-221287_ref43","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamaneurol.2016.1017","article-title":"Association of cerebral microbleeds with cognitive decline and dementia","volume":"73","author":"Akoudad","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-221287_ref44","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jalz.2019.04.015","article-title":"Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer\u2019s disease","volume":"15","author":"Bos","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref45","doi-asserted-by":"crossref","first-page":"e1123","DOI":"10.1212\/WNL.0000000000012482","article-title":"Association of midlife plasma amyloid-\u03b2 levels with cognitive impairment in late life: The ARIC Neurocognitive Study","volume":"97","author":"Sullivan","year":"2021","journal-title":"Neurology"},{"key":"10.3233\/JAD-221287_ref46","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1038\/s41467-021-23746-0","article-title":"Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations","volume":"12","author":"Cullen","year":"2021","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-221287_ref47","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/brain\/awaa054","article-title":"Plasma tau, neurofilament light chain and amyloid-\u03b2 levels and risk of dementia; a population-based cohort study","volume":"143","author":"de Wolf","year":"2020","journal-title":"Brain"},{"key":"10.3233\/JAD-221287_ref48","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archneurol.2011.1841","article-title":"Plasma amyloid-\u03b2 as a predictor of dementia and cognitive decline","volume":"69","author":"Koyama","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-221287_ref49","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/brain\/awab163","article-title":"Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"10.3233\/JAD-221287_ref50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","article-title":"Performance of fully automated plasma assays as screening tests for Alzheimer disease-related \u03b2-amyloid status","volume":"76","author":"Palmqvist","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-221287_ref51","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/alz.12466","article-title":"Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities","volume":"18","author":"Syrjanen","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref52","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease","volume":"17","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/alz.12647","article-title":"Medical comorbidities and ethnicity impact plasma Alzheimer\u2019s disease biomarkers: Important considerations for clinical trials and practice","volume":"19","author":"O\u2019Bryant","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref54","doi-asserted-by":"crossref","first-page":"650679","DOI":"10.3389\/fnagi.2021.650679","article-title":"Blood pressure level is associated with changes in plasma A\u03b21-40 and A\u03b21-42 levels: A cross-sectional study conducted in the suburbs of Xi\u2019an, China","volume":"13","author":"She","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-221287_ref55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-180140","article-title":"Elevation of plasma amyloid-\u03b2 level is more significant in early stage of cognitive impairment: A population-based cross-sectional study","volume":"64","author":"Wang","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221287_ref56","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.2005.072306","article-title":"Education and rates of cognitive decline in incident Alzheimer\u2019s disease","volume":"77","author":"Scarmeas","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-221287_ref57","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awh451","article-title":"The 9 year cognitive decline before dementia of the Alzheimer type: A prospective population-based study","volume":"128","author":"Amieva","year":"2005","journal-title":"Brain"},{"key":"10.3233\/JAD-221287_ref58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2318-8-36","article-title":"Smoking, dementia and cognitive decline in the elderly, a systematic review","volume":"8","author":"Peters","year":"2008","journal-title":"BMC Geriatr"},{"key":"10.3233\/JAD-221287_ref59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/gerona\/gls187","article-title":"The role of peripheral inflammatory markers in dementia and Alzheimer\u2019s disease: A meta-analysis","volume":"68","author":"Koyama","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-221287_ref60","doi-asserted-by":"crossref","first-page":"e1256","DOI":"10.1212\/WNL.0000000000007094","article-title":"Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study","volume":"92","author":"Walker","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-221287_ref61","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.clinbiochem.2013.05.070","article-title":"Inflammatory biomarkers for predicting cardiovascular disease","volume":"46","author":"Stoner","year":"2013","journal-title":"Clin Biochem"},{"key":"10.3233\/JAD-221287_ref62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","article-title":"Adhesion molecules and atherosclerosis","volume":"170","author":"Blankenberg","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.3233\/JAD-221287_ref63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","article-title":"Atherosclerosis, apolipoprotein E and the prevalence of dementia and Alzheimer\u2019s disease in a population-based study: The Rotterdam Study","volume":"349","author":"Hofman","year":"1997","journal-title":"Lancet"},{"key":"10.3233\/JAD-221287_ref64","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0197-4580(99)00110-4","article-title":"Vascular risk factors for Alzheimer\u2019s disease:","volume":"21","author":"Breteler","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-221287_ref65","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jalz.2016.08.004","article-title":"Sex biology contributions to vulnerability to Alzheimer\u2019s disease: A think tank convened by the Women\u2019s Alzheimer\u2019s Research Initiative","volume":"12","author":"Snyder","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref66","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1037\/pag0000070","article-title":"Sex differences in cognitive trajectories in clinically normal older adults","volume":"31","author":"McCarrey","year":"2016","journal-title":"Psychol Aging"},{"key":"10.3233\/JAD-221287_ref67","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1017\/S1355617718000425","article-title":"Change in cognitive performance from midlife into old age: Findings from the Midlife in the United States (MIDUS) study","volume":"24","author":"Hughes","year":"2018","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-221287_ref68","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jalz.2013.10.005","article-title":"Gender and incidence of dementia in the Framingham Heart Study from mid-adult life","volume":"11","author":"Ch\u00eane","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref69","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3233\/JAD-180141","article-title":"Differences between women and men in incidence rates of dementia and Alzheimer\u2019s disease","volume":"64","author":"Beam","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221287_ref70","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamaneurol.2017.1359","article-title":"Association of plasma total tau level with cognitive decline and risk of mild cognitive impairment or dementia in the Mayo Clinic Study on Aging","volume":"74","author":"Mielke","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-221287_ref71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in Alzheimer\u2019s disease","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-221287_ref72","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","article-title":"Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer\u2019s disease","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-221287_ref73","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-221287_ref74","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","article-title":"Assessment of plasma total tau level as a predictive biomarker for dementia and related endophenotypes","volume":"76","author":"Pase","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-221287_ref75","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/diabetes.53.3.687","article-title":"Magnetic resonance imaging of the brain in diabetes","volume":"53","author":"Schmidt","year":"2004","journal-title":"Diabetes"},{"key":"10.3233\/JAD-221287_ref76","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neulet.2013.06.063","article-title":"Brain cortical thickness in the general elderly population: The Rotterdam Scan Study","volume":"550","author":"van Velsen","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-221287_ref77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11892-005-0069-1","article-title":"Diabetes and brain aging: Epidemiologic evidence","volume":"5","author":"Launer","year":"2005","journal-title":"Curr Diab Rep"},{"key":"10.3233\/JAD-221287_ref78","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/jgs.12382","article-title":"Long-Term Variability of Inflammatory Markers and Associated Factors in a Population-Based Cohort","volume":"61","author":"Nash","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-221287_ref79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-221287_ref80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.10265","article-title":"Early inflammation and dementia: A 25-year follow-up of the Honolulu-Asia aging study","volume":"52","author":"Schmidt","year":"2002","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-221287_ref81","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00004872-200310000-00002","article-title":"C-reactive protein and interleukin-6 in vascular disease","volume":"21","author":"Rattazzi","year":"2003","journal-title":"J Hypertens"},{"key":"10.3233\/JAD-221287_ref82","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.3233\/JAD-221287_ref83","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: Mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-221287_ref84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-200901","article-title":"Utility of plasma neurofilament light in the 1Florida Alzheimer\u2019s Disease Research Center (ADRC)","volume":"79","author":"Barker","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221287_ref85","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-018-0649-3","article-title":"Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration","volume":"7","author":"Ashton","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-221287_ref86","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-221287_ref87","doi-asserted-by":"crossref","first-page":"e12295","DOI":"10.1002\/dad2.12295","article-title":"Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community-based sample of 70-year-olds","volume":"14","author":"Dittrich","year":"2022","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-221287_ref88","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jn\/nxab381","article-title":"BMI and allostatic load are directly associated with longitudinal increase in plasma neurofilament light among urban middle-aged adults","volume":"152","author":"Beydoun","year":"2022","journal-title":"J Nutr"},{"key":"10.3233\/JAD-221287_ref89","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-221287_ref90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1192\/bjp.159.2.213","article-title":"Heavy drinking as a risk factor for depression and dementia in elderly men","volume":"159","author":"Saunders","year":"1991","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-221287_ref91","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/S2468-2667(18)30022-7","article-title":"Contribution of alcohol use disorders to the burden of dementia in France 2008-13: A nationwide retrospective cohort study","volume":"3","author":"Schwarzinger","year":"2018","journal-title":"Lancet Public Health"},{"key":"10.3233\/JAD-221287_ref92","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/01.ede.0000181307.30826.6c","article-title":"Binge drinking in midlife and dementia risk","volume":"16","author":"J\u00e4rvenp\u00e4\u00e4","year":"2005","journal-title":"Epidemiology"},{"key":"10.3233\/JAD-221287_ref93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(02)07493-7","article-title":"Alcohol consumption and risk of dementia: The Rotterdam Study","volume":"359","author":"Ruitenberg","year":"2002","journal-title":"Lancet"},{"key":"10.3233\/JAD-221287_ref94","doi-asserted-by":"crossref","first-page":"k2927","DOI":"10.1136\/bmj.k2927","article-title":"Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study","volume":"362","author":"Sabia","year":"2018","journal-title":"BMJ"},{"key":"10.3233\/JAD-221287_ref95","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2105\/AJPH.90.8.1254","article-title":"A longitudinal study of drinking and cognitive performance in elderly Japanese American men: The Honolulu-Asia Aging Study","volume":"90","author":"Galanis","year":"2000","journal-title":"Am J Public Health"},{"key":"10.3233\/JAD-221287_ref96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-160665","article-title":"How does exercise reduce the rate of age-associated cognitive decline? A review of potential mechanisms","volume":"55","author":"Kennedy","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-221287_ref97","doi-asserted-by":"crossref","first-page":"871947","DOI":"10.3389\/fneur.2022.871947","article-title":"Characterizing plasma biomarkers of Alzheimer\u2019s in a diverse community-based cohort: A cross-sectional study of the HAB-HD Cohort","volume":"13","author":"Hall","year":"2022","journal-title":"Front Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-221287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:07Z","timestamp":1777370887000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-221287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":94,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-221287","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]}}}